StockTalks
-
If I had free $, I'd start my position in $GALE, especially after learning from COL GEP of AF's inaccuracies. Nov 27, 2012
-
$BPAX, AH's -12.5%, $16.9 M RDO caused the decline. Phase 3 results, NDA; are 2011 binary events that may make a buy after a RDO a winner. Dec 27, 2010
Latest Comments
-
retiredpharma on EASD 2010: Important Antibody Data from Novo Nordisk, Amylin and Generex RJ, Any ideas as to why those receiving Oralyn ...
-
MollyJayne on EASD 2010: Important Antibody Data from Novo Nordisk, Amylin and Generex I would like to compliment JR Steffens' thought...
-
Diversify on In Support of Generex from TheStreet Generex is still a story in progress, but it is...
-
Trademissuh on In Support of Generex from TheStreet Mr. Fuerenstein does not do adequate due diliga...
-
User 8204 on In Support of Generex from TheStreet I agree, the Street article seemed to have a pe...
Most Commented
- In Support of Generex from TheStreet (4 Comments)
- EASD 2010: Important Antibody Data from Novo Nordisk, Amylin and Generex (2 Comments)
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.

















Full Index of Posts 2 posts, page 1 of 1
EASD 2010: Important Antibody Data from Novo Nordisk, Amylin and Generex
In Support of Generex from TheStreet